The application of DCE-MRI in diagnosing breast cancer

来源 :中德临床肿瘤学杂志(英文版) | 被引量 : 0次 | 上传用户:xiazixu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: The aim of the study was to further explore the diagnostic value of breast dynamic contrast enhancement (DCE), and improve specificity of breast cancer diagnosis. Methods: The 93 patients with 105 breast masses were performed with routine magnetic resonance (MR) scan and DCE scan. Results: 1. Morphological manifestations and pathologic findings: 105 masses of enhance forms could be divided into six types: (1) No enhancement, 9 masses (breast cyst); (2) The heterogeneous enhancement, 31 masses (fiber adenoma, 9; breast cancer, 11; mammary gland hyperplasia, 10; leafy tumor, 1); (3) The unheterogeneous enhancement, 42 masses (fiber adenoma, 5; the hyperplasia, 3; breast cancer,33; leafy tumor, 1); (4) Ring enhancement, 17 masses (breast cancer, 15; fiber adenoma, 1 and inflammation, 1); (5) Reticular enhancement, 2 cases (gigantic breast, 1 and inflammation, 1). (6) Duct shape enhancement, 4 (hyperplasia, 1; duct carcinoma, 3). 2. Enhancement slope and pathology results: The maximum slope in 62 malignant masses was equally 19.19 ± 8.13, maximum slopes in 43 benign masses was equally 9.46 ± 6.64, the difference had a very significance (P < 0.01). In 42 masses with II type curves, the maximum slope of 24 malignant focuses were 17.52 ± 6.39, while 18 benign focuses 8.33 ± 5.47, the difference had a very significance (P < 0.01). Use a test-receiver to work curve (ROC curve) progress analysis,with 14.85 for critical point, sensibility for 67%, specificity for 83%; with 17.10 for critical value, the specificity was 100%. 3.Curve type and pathological results: According to general type standard, type I of single-phase curve, 20 masses; type II of platform type curve, 42 and III type curve type of washout, 43. A group of six kinds of forms were as follows: (1) No increased signal strength curve, 9 (cyst); (2) The curve signal strength slowly increasing, 6 (hyperplasia 2, fiber adenoma 2, chronic inflammation 1, duct carcinoma 1); (3) The intensity of curve after rapid increase early, continued to increase slowly 5 (hyperplasia 4, inflammatory breast cancer 1); (4) Curve early signal strength increasing rapidly formed the stop after middle-late platform (platform type), 42 (hyperplasia 9, fiber adenoma 8, leafy tumor 1, and breast cancer 24); (5) Early signal strength rapid increase arrived the peak then rapid declined (outflow type), 40 (hyperplasia 1, fiber adenoma 5, leafy tumor 1, breast 33); (6) Early signal strength increase quickly reached a peak, after platform period, then rising quickly again, and all of 3 for breast cancer. Conclusion: Enhancement morphological characteristics of breast cancer such as duct or ring enhancement had diagnostic value. Maximum slope in benign or malignant lesions, particularly in the differential diagnosis of type II curve played an important role. Formation mechanism of type II curve might be that an obstacle blood backflow of blood vessels by vascular tumor emboli or tumor compression.
其他文献
自噬是存在于细胞内高度保守的分解途径,以降解细胞内大分子物质和细胞内容物,包括长寿蛋白和细胞器.在生理情况下,心肌细胞的自噬对更新细胞器起重要作用;在应激情况下,自噬
目的 探讨首诊护理负责制对产科护理质量的影响.方法 将2010年7-12月住院分娩的798例产妇作为观察组,采用首诊护理模式;将2010年1-6月住院分娩的752例产妇作为对照组,采用传
目的 对准分子激光原位角膜磨镶术(LASIK)后早期应用硅水凝胶材质的角膜接触镜进行临床观察.方法 前瞻性自身对照研究.25例近视患者(50眼)在LASIK术毕时随机选一眼给予PureVi
目的观察白藜芦醇对非酒精性脂肪肝(NAFL)小鼠肝细胞PPARγ表达的影响。方法小鼠分为正常对照(NC)组、高脂喂养(HF)组和白藜芦醇干预(HF+Res)组。检测肝脏脂肪变性程度及PPAR
目的 探讨腰肋悬空位和俯卧位经皮肾镜碎石术对患者主观感觉的影响.方法 100例经皮肾镜碎石术患者,随机分为腰肋悬空位和俯卧位两组,每组50例,采用视觉模拟评分(VAS评分)记录
目的分析研究网络直报后传染病的流行病学特征,掌握防控措施。方法运用描述流行病学对本院2005年1月1日-2011年12月31日的传染病网络直报和疫情监测资料进行统计分析。结果网
目的:提高贲门癌患者术后并发重症哮喘的护理水平.方法:通过严密的病情观察、呼吸道护理、术后补液护理、雾化吸入及心理护理,改善贲门癌术后患者生存质量.结果:35例重症哮喘
目的 探讨腹腔镜下行输卵管整形术治疗输卵管性不孕症的疗效及影响因素,为临床提供诊治依据.方法 回顾性分析本院腹腔镜下行输卵管整形术治疗100例输卵管性不孕症患者临床资
以表皮生长因子受体(EGFR)为靶点的酪氨酸酶抑制剂(TKI)是近年来非小细胞肺癌(NSCLC)治疗的重大突破.但是随着临床的广泛应用,耐药成为新的难点.新近研究已发现对EGFRTKI的耐
Objective: The aim of this study was to define the maximum-tolerated dose (MTD) and observe the toxicity of escalating topotecan combined whole brain radiothera